CVS Health (CVS) Q4 and Annual 2025 Earnings
CVS Health reported Q4 2025 revenue of $105.69B (+8.2% YoY), beat analyst consensus of $103.70B by $2.0B. Diluted EPS came in at $1.09 (-8.4% YoY), beat the $1.00 consensus by $0.09. CVS Health reports across 3 business segments, led by Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about CVS Health's Q4 2025 earnings report.
CVS Health (CVS) reported Q4 2025 earnings on February 10, 2026 before market open.
CVS Health reported revenue of $105.69B and diluted EPS of $1.09 for Q4 2025.
Revenue beat the consensus estimate of $103.70B by $2.0B. EPS beat the consensus estimate of $1.00 by $0.09.
Compared to the same quarter a year prior, revenue grew 8.2% from $97.7B a year earlier and diluted EPS declined 8.4% from $1.19.
You can read the 8-K earnings release (0000064803-26-000009) and the 10-K periodic report (0000064803-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.